Anadys Pharmaceuticals to Present at the CanAccord Adams Hepatitis C Conference - FOXBusiness.com

"SAN DIEGO, March 31, 2009 /PRNewswire-FirstCall via COMTEX/ ----Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS) announced today that it will present at the CanAccord Adams Hepatitis C Conference on Tuesday, April 7, 2009 at 2:00 p.m. EDT (11:00 a.m. PDT). The conference is being held at the InterContinental The Barclay Hotel in New York City.

Steve Worland, Ph.D., President and Chief Executive Officer of Anadys, will provide an overview of Anadys and its clinical programs in development for hepatitis C: ANA598 and ANA773."